Incyte

Incyte

Wilmington, Delaware, United States
Wilmington United States
Employees:
980
Market Cap:
$26.6 billion
Revenue:
$1.11 billion
5 Year Trend:
63.5%
Net Income:
$18.22 million
NASDAQ:
INCY
Founded:
1991

Incyte, Corp is an American pharmaceutical company based in Alapocas, Delaware. Incyte has one drug which has been approved by the U.S. Wikipedia

Incyte
Wilmington, Delaware, United States
Wilmington United States
Employees:
980
Market Cap:
$26.6 billion
Revenue:
$1.11 billion
5 Year Trend:
63.5%
Net Income:
$18.22 million
NASDAQ:
INCY
Founded:
1991

Incyte, Corp is an American pharmaceutical company based in Alapocas, Delaware. Incyte has one drug which has been approved by the U.S. Wikipedia

Mar 16, 2:43 PM

Have questions about Jakafi (ruxolitinib)? Were ready to help. Please call IncyteCARES at 1-855-4-Jakafi (1-855-452-5234) Monday through Friday, 8 AM to 8 PM, ET. Jakafi (ruxolitinib) is a prescription medicine used to treat people with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it. Jakafi is also used to treat certain types of myelofibrosis. Jakafi can cause serious side effects including low blood counts and infection. Some people who take Jakafi have developed certain types of non-melanoma skin cancers. Increases in blood cholesterol levels can also occur. The most common side effects of Jakafi include low platelet count, low red blood cell counts, bruising, dizziness, headache. Tell your doctor about any side effect that bothers you or that does not go away. To learn more about these and other risks, please read the Important Safety Information and Full Prescribing Information at http://bit.ly/Indication_ISI.

Jun 9, 11:07 AM

Take positive steps to learn about rare blood cancers such as polycythemia vera (PV) and myelofibrosis (MF). Get helpful support and resources now: http://www.jakafi.com/support-and-resources.aspx Jakafi (ruxolitinib) is a prescription medicine used to treat people with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it. Jakafi is also used to treat certain types of myelofibrosis. Jakafi can cause serious side effects including low blood counts and infection. Some people who take Jakafi have developed certain types of non-melanoma skin cancers. Increases in blood cholesterol levels can also occur. The most common side effects of Jakafi include low platelet count, low red blood cell counts, bruising, dizziness, headache. Tell your doctor about any side effect that bothers you or that does not go away. To learn more about these and other risks, please read the Important Safety Information and Full Prescribing Information at http://bit.ly/Indication_ISI.

May 31, 0:08 PM

Get fast, easy access to 15 organizations that offer helpful information and support. Connect here: http://www.jakafi.com/support-and-resources.aspx Jakafi (ruxolitinib) is a prescription medicine used to treat people with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it. Jakafi is also used to treat certain types of myelofibrosis. Jakafi can cause serious side effects including low blood counts and infection. Some people who take Jakafi have developed certain types of non-melanoma skin cancers. Increases in blood cholesterol levels can also occur. The most common side effects of Jakafi include low platelet count, low red blood cell counts, bruising, dizziness, headache. Tell your doctor about any side effect that bothers you or that does not go away. To learn more about these and other risks, please read the Important Safety Information and Full Prescribing Information at http://bit.ly/Indication_ISI.

May 25, 1:09 PM

Searching for information about intermediate or high-risk myelofibrosis (MF)? Visit here to learn more about MF and a treatment option called Jakafi (ruxolitinib): http://www.jakafi.com/primary-myelofibrosis.aspx Jakafi (ruxolitinib) is a prescription medicine used to treat certain types of myelofibrosis. Jakafi can cause serious side effects including low blood counts and infection. Some people who take Jakafi have developed certain types of non-melanoma skin cancers. Increases in blood cholesterol levels can also occur. The most common side effects of Jakafi include low platelet count, low red blood cell counts, bruising, dizziness, headache. Tell your doctor about any side effect that bothers you or that does not go away. To learn more about these and other risks, please read the Important Safety Information and Full Prescribing Information at http://bit.ly/Indication_ISI.

12 jobs at Incyte

Jobs in